White River Diagnostic Clinic
Batesville, Arkansas, 72501, United States
NCT Number: NCT01375725
The purpose of this study is to measure prothrombin time (PT) expressed in International Normalised Ratio (INR) units in persons receiving coumadin (warfarin) treatment on an experimental device and a commercially available device. This study will involve taking a finger-puncture and testing onto a strip and meter system for the experimental and commercially available devices.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Batesville, Arkansas, 72501, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Five days to collect data and up to two weeks to generate correlation graph
To determine the correlation of PT/INR values between an experimental and commercial device
Looking for future studies?
Notify MeUniversal Biosensors Pty Ltd
Industry
Mobius PT-INR Accuracy Clinical Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04401436
COVID-19, Cardiovascular Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06372483
Cardiovascular Diseases, Coagulation Disorder
Groningen, Netherlands
View Trial DetailsNCT05449834
Cardiovascular Diseases, Coagulopathy
Newcastle, New South Wales, Australia
View Trial DetailsNCT06635564
Bleeding Disorder, Brain Diseases
Vienna, Austria
View Trial Details